SynthesisJAMA network open2021

Comparison of Hepatotoxicity Associated With New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients With Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis.

Zhe Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.